GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Esperion to Receive an Upfront Payment and Near-Term Milestones Along with a Profitable Transfer Price on Product Sales –ANN ARBOR, Mich., March 03, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics ...

The global cholesterol test market size was valued at USD 8.24 billion in 2024 and is projected to reach from USD 9.12 ...

Cholesterol is a waxy, fat-like substance that is made in your liver and travels throughout your bloodstream. It may not ...

Researchers across 14 medical centers in China, including Peking University People's Hospital, have found that an ...

As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...

Late-breaking results presented at AAD show 80% or more scalp hair coverage at Week 36 in 42.4% of adolescents receiving baricitinib 4 mg INDIANAPOLIS /PRNewswire/ -- Late-breaking results from Eli ...

Total Revenue Grew 186% Y/Y to $332.3 Million; FY24 U.S. Net Product Revenue Grew 48% Y/Y to $115.7 Million ––Q4 Total Revenue Grew 114% ...

Clarence Wilkerson, 34, died two years ago while in custody of Ashland police. Video of his interaction with police was uploaded online and shared widely.

More than 30 percent of adults in Taiwan have hyperlipidemia (high cholesterol), the Health ... as nicotine can reduce HDL-C levels and cause blood pressure to increase, the agency said. People with ...

Q4 2024 Earnings Call Transcript March 3, 2025 Fortrea Holdings Inc. misses on earnings expectations. Reported EPS is $0.18 ...